- Report
- August 2025
- 187 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- November 2025
- 150 Pages
Global
From €3336EUR$3,750USD£2,894GBP
- Report
- November 2025
- 150 Pages
Global
From €3336EUR$3,750USD£2,894GBP
- Report
- September 2025
- 150 Pages
Global
From €3959EUR$4,450USD£3,435GBP
- Report
- November 2025
- 143 Pages
Global
From €3514EUR$3,950USD£3,049GBP
- Report
- November 2025
- 148 Pages
Global
From €3514EUR$3,950USD£3,049GBP
- Report
- July 2025
- 350 Pages
Global
From €4403EUR$4,949USD£3,820GBP
- Report
- July 2025
- 350 Pages
Global
From €4403EUR$4,949USD£3,820GBP
- Report
- June 2025
- 400 Pages
Global
From €4403EUR$4,949USD£3,820GBP
- Report
- July 2025
- 350 Pages
Global
From €4403EUR$4,949USD£3,820GBP
- Report
- June 2025
- 400 Pages
Global
From €4403EUR$4,949USD£3,820GBP
- Report
- October 2025
- 160 Pages
Global
From €3514EUR$3,950USD£3,049GBP
- Report
- October 2025
- 160 Pages
Global
From €3514EUR$3,950USD£3,049GBP
- Report
- October 2025
- 160 Pages
Global
From €3514EUR$3,950USD£3,049GBP
- Report
- May 2025
- 89 Pages
Global
From €3500EUR$4,215USD£3,143GBP
- Report
- May 2025
- 75 Pages
Global
From €3500EUR$4,215USD£3,143GBP
- Report
- December 2025
- 150 Pages
Global
From €3425EUR$3,850USD£2,972GBP
€4314EUR$4,850USD£3,743GBP
- Report
- August 2025
- 150 Pages
Global
From €3425EUR$3,850USD£2,972GBP
€4314EUR$4,850USD£3,743GBP
- Report
- June 2025
- 150 Pages
Global
From €3425EUR$3,850USD£2,972GBP
€4314EUR$4,850USD£3,743GBP
- Report
- June 2025
- 150 Pages
Global
From €3425EUR$3,850USD£2,972GBP
€4314EUR$4,850USD£3,743GBP

The Cardiac Valve market is a segment of the Cardiovascular Devices industry, which includes a range of products used to diagnose and treat heart conditions. Cardiac valves are used to regulate the flow of blood through the heart, and can be either mechanical or biological. Mechanical valves are typically made of metal and are designed to last for many years, while biological valves are made of animal tissue and are designed to be replaced over time. Both types of valves are used to treat a variety of heart conditions, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation.
The Cardiac Valve market is highly competitive, with a number of companies offering a range of products. Major players in the market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. Other companies in the market include CryoLife, Symetis, and Neovasc. Show Less Read more